ALPEX PHARMA SA

OUR STORY

Founded in 1988, Alpex was created with the intention to develop exciting and thoughtful medicines in untreated areas. Soon after its inception, Irish powerhouse, Elan Pharma saw Alpex’s potential and acquired it – growing the company’s focus on Alpex’s burgeoning neuroscience drug development program.Alpex quickly became Elan’s Swiss research and development facility, tucked away from its headquarters in Ireland, focused on developing further specialized products, and subsequently developed multiple propriety drugs and patents. Many of Alpex’s products and skills offer unique delivery systems that can be applied to a number of existing drugs today.

As Alpex grew, it developed a focused customer-first strategy and forged a global client base attracting many of the world’s leading pharmaceutical companies as long term drug development partners. In 2020, a pair of entrepreneurs acquired Alpex with the vision to scale their passion for longevity. Combining Alpex’s world class technologies and fundamental pharmaceutical infrastructure with novel medicine and the plethora of modern Active pharmaceutical ingredients – Alpex is ushering a new generation of drug development.

Now, 35 years after it’s inception, Alpex has a global reputation and independent brand for Swiss superior high quality and precision, and continues to successfully developed dozens of new drugs for the most demanding markets across the globe.

ALPEX PHARMA IS A TECHNOLOGY COMPANY WITH EXPERTISE IN DRUG DEVELOPMENT & DELIVERY SOLUTIONS THAT RELEASE THE TRUE VALUE OF ACTIVE PHARMACEUTICAL INGREDIENTS (APIS)